---
title: "Autobio Diagnostics Co., Ltd (603658.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603658.SH.md"
symbol: "603658.SH"
name: "Autobio Diagnostics Co., Ltd"
industry: "Health Care Supplies"
datetime: "2026-05-20T22:46:30.356Z"
locales:
  - [en](https://longbridge.com/en/quote/603658.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603658.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603658.SH.md)
---

# Autobio Diagnostics Co., Ltd (603658.SH)

## Company Overview

Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products in China and internationally. The company offers immunoassay, biochemistry, and microbiology products; reagents and instruments; and technical and support, and training services, as well as engages in biology research and development activities. Its immunoassay products consist of AutoLumo S900 and AutoLumo A1860 that provides user experience for small and medium size labs; AutoLumo A6200/A6600, an automatic immunoassay analyzer; AutoLumo A2000 Plus, an automated chemiluminescence immunoassay analyzer; PHOmo microplate readers; LUmo microplate luminometers; and iWO and iWO-960 microplate washers.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | CN Market |
| Website | [www.autobio.com.cn](https://www.autobio.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:11.000Z

**Overall: C (0.45)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 15 / 40 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -3.55% |  |
| Net Profit YoY | -9.26% |  |
| P/B Ratio | 2.15 |  |
| Dividend Ratio | 3.65% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 19749220171.31 |  |
| Revenue | 4230192711.41 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 11.47% | B |
| Profit Margin | 24.50% | A |
| Gross Margin | 66.64% | A |
| Revenue YoY | -3.55% | D |
| Net Profit YoY | -9.26% | D |
| Total Assets YoY | 2.29% | C |
| Net Assets YoY | 3.18% | C |
| Cash Flow Margin | 127.77% | B |
| OCF YoY | -3.55% | D |
| Turnover | 0.35 | D |
| Gearing Ratio | 24.40% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Autobio Diagnostics Co., Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-3.55%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-9.26%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.15",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "3.65%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "19749220171.31",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "4230192711.41",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "11.47%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "24.50%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "66.64%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-3.55%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-9.26%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.29%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "3.18%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "127.77%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "-3.55%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.35",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "24.40%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 18.40 | 3/40 | 19.94 | 19.09 | 18.54 |
| PB | 2.08 | 19/40 | 2.62 | 2.42 | 2.29 |
| PS (TTM) | 4.51 | 15/40 | 5.20 | 4.97 | 4.74 |
| Dividend Yield | 3.78% | 5/40 | 3.63% | 3.40% | 3.21% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Snibe (300832.SZ) | A | D | C | A | C | B |
| 02 | Winner Medical (300888.SZ) | B | B | B | B | B | B |
| 03 | Fuerjia (301371.SZ) | B | C | D | A | B | B |
| 04 | MTM (688029.SH) | B | B | B | A | B | B |
| 05 | Endovastec (688016.SH) | A | B | D | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-13T16:00:00.000Z

Total Analysts: **7**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 5 | 71% |
| Overweight | 1 | 14% |
| Underweight | 1 | 14% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 33.32 |
| Highest Target | 44.20 |
| Lowest Target | 31.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/603658.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/603658.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/603658.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/603658.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**